Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Military Medicine|August 25, 2022
Relation of Vitamin D Level, BMI, and Location of Lower Extremity Stress Fractures in Military TraineesB Holt Zalneraitis, Elizabeth Huuki, Linda C Benavides, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|September 15, 2017
The Golden Hour Offset Surgical Treatment Team Operational Concept: Experience of the 102nd Forward Surgical Team in Operation Freedom's Sentinel 2015-2016Jerry M Benavides, Linda C Benavides, Diane F Hale, et al.
The Journal of Surgical Research|June 2, 2009
Preoperative thyroid ultrasound in all patients undergoing parathyroidectomy?Jeremy D Gates, Linda C Benavides, Craig D Shriver, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|September 15, 2017
Surgical Instrument Sets for Special Operations Expeditionary Surgical TeamsDiane F Hale, Justin C Sexton, Linda C Benavides, et al.
The Journal of Trauma and Acute Care Surgery|July 7, 2025
Breaking point: Musculoskeletal combat injuries in Iraq, Afghanistan, and Syria-Epidemiology and future directions of care on the battlefield after over two decades of warJerome M Benavides, Linda C Benavides, Luke Pumiglia, et al.
The Journal of Trauma and Acute Care Surgery|March 24, 2017
Deployed skills training for whole blood collection by a special operations expeditionary surgical teamLinda C Benavides, Iain M Smith, Jerome M Benavides, et al.
Cancer|November 20, 2009
Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-04Mark G Carmichael, Linda C Benavides, Jarrod P Holmes, et al.
Military Medicine|January 27, 2021
Hypocalcemia in Military Casualties From Point of Injury to Surgical Teams in AfghanistanJeffrey R Conner, Linda C Benavides, Stacy A Shackelford, et al.
Cancer|September 17, 2010
Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Jarrod P Holmes, Guy T Clifton, Ritesh Patil, et al.
Cancer|August 30, 2008
Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02Jarrod P Holmes, Jeremy D Gates, Linda C Benavides, et al.
Pageof 2